Please login to the form below

Not currently logged in
Email:
Password:

cancer

This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy. Its first CAR therapy will be tested in patients with ovarian cancer. ... The company’s in-house tech uses messenger RNA to engineer peripheral blood mononuclear cells or macrophages so they

Latest news

More from news
Approximately 634 fully matching, plus 1,498 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    The best example is probably Jem Rashbass’successful attempt to consolidate NHS cancer data through the National Disease Registration Service as part of Public Health England.

  • 30 Women Leaders in UK Healthcare

    pharma’to become chief executive of Redx, a promising UK biotech company focused on novel cancer and fibrosis treatments. ... for Lynparza, the first in class PARP inhibitor now approved in ovarian and breast cancers.

  • 30 Women Leaders in UK Healthcare (part 2)

    ecosystem. In her 25-plus years in the sector, her investments have resulted in the launch of six drugs, spanning inflammatory and autoimmune disease and cancer. ... 20. Prof Rebecca Fitzgerald, MRC Cancer Unit, University of Cambridge, and Honorary

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    policy campaigning and research, and putting breast cancer firmly on the public agenda. ... kind. Its stated ambition is that, by 2050, everyone who develops breast cancer will live.

  • If you’re going global, go local and go early If you’re going global, go local and go early

    Similarly, the inspiration for a recent global women’s cancer campaign originated from work with colleagues based in the Middle East - an area that might be considered an unconventional source for

More from intelligence
Approximately 6 fully matching, plus 233 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 195 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 33 fully matching, plus 153 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics